Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Tongue Neoplasms 1Carcinoma, Squamous Cell 1

Interventions

Cisplatin 10Cetuximab 7Radiotherapy, Intensity-Modulated 5Radiotherapy 4Docetaxel 3Sorafenib 2Paclitaxel 2Fluorouracil 2Erlotinib Hydrochloride 2Celecoxib 2temsirolimus 1saracatinib 1ixabepilone 1cediranib 1adavosertib 1Zinc Oxide 1Vorinostat 1Vaccinium myrtillus extract 1Trioxsalen 1Taxes 1Standard of Care 1Soybean Proteins 1Sirolimus 1Ritonavir 1Practice Guidelines as Topic 1Platinum 1Phototherapy 1Photochemotherapy 1Observation 1N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl-6-(5-((methylsulfonyl)ethyl)aminomethyl)-2-furyl)-4-quinazolinamine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Tongue Neoplasms × Glossectomy × Clear all
NCT02985255 2016-12-07

Role of Neo-adjuvant Chemotherapy in Tongue Preservation in Locally Advanced Squamous Cell Carcinoma of Oral Tongue

HealthCare Global Enterprise Ltd.

Phase 2 Unknown
30 enrolled

Carcinoma, Squamous Cell, Tongue Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡